Aclaris Therapeutics (ACRS) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Aclaris Therapeutics (ACRS) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Aclaris Therapeutics

· ACRS

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

777.21 M

-0.38%

General

Market Cap: $777.21M
Enterprise Value: $715.46M
Shares Outstanding: 139,660,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 95.61%
Operating Margin: -1050.16%
Net Profit Margin: -921.50%
FCF Margin: -756.50%
ROA: -42.15%
ROE: -61.65%
ROIC: -56.99%
Current Ratio: 3.46
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 89.38
P/FCF: —
P/B: 5.90
EV/EBITDA: -9.52

Growth

Rev 1Y: -58.19%
Rev 1Y Fwd Est: -24.05%
Rev 3Y (CAGR): -35.93%
Rev 5Y (CAGR): 3.84%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $8.22M
Gross Margin: 95.61%
Operating Expenses: $94.17M
Operating Income: -$86.31M
Net Profit: -$75.74M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $19.17M
Working Capital: $69.52M
Total Assets: $179.69M
Net Debt: -$19.17M
Total Liabilities: $55.11M
Total Equity: $124.58M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$62.06M
Cash Flow from Investing: $3.53M
Cash Flow from Financing: $52.29M
Free Cash Flow: -$62.18M
Capital Expenditures: $118K